Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases at EHA 2022
-
Evusheld significantly prevented COVID-19 disease progression or death in TACKLE Phase III treatment trial
-
Enhertu reduced the risk of disease progression or death by 50% vs. chemotherapy in patients with HER2-low metastatic breast cancer with HR-positive and HR-negative disease
-
Calquence plus obinutuzumab demonstrated sustained survival benefit in 1st-line chronic lymphocytic leukaemia with 90% of patients surviving five years in ELEVATE-TN trial
-
AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic
-
Vaxzevria approved in the EU as third dose booster against COVID-19
-
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
-
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19
-
PT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine, significantly reduced the risk of a severe exacerbation compared to albuterol by 27% in patients with asthma
-
Human ventricular progenitor cells promote the formation of new heart tissue following a heart attack
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
